| Non-benzodiazepines |
| Eszopiclone |
1-mg, 2-mg, and 3-mg tablets |
Primarily used for sleep-onset and maintenance insomnia; intermediate-acting; no short-term usage restriction |
| Zolpidem |
5-mg, 10-mg tablets |
Primarily used for sleep-onset insomnia; short-to intermediate-acting; primarily used for sleep-onset and maintenance insomnia; controlled-release |
| Zaleplon |
5-mg, 10-mg capsules |
Primarily used for sleep-onset insomnia; maintenance insomnia as long as a 4-hour period is available for further sleep; short-acting |
| Benzodiazepines |
| Estazolam |
1-mg, 2-mg tablets |
Short-to intermediate-acting |
| Temazepam |
7.5-mg, 15-mg, and 30-mg capsules |
Short-to intermediate-acting |
| Triazolam |
0.125-mg, 0.25-mg tablets |
Short-acting |
| Flurazepam |
15-mg, 30-mg capsules |
Long-acting; risk of residual daytime drowsiness |
| Melatonin Receptor Agonists (Non-Scheduled) |
| Ramelteon |
8-mg tablet |
Primarily used for sleep-onset insomnia; short-acting; no short-term usage restriction |
| Orexin Receptor Antagonist |
| Suvorexant |
5-mg, 10-mg, 15-mg, and 20-mg tablets |
Indicated for the treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance. Lowest effective dose should be used. |
